Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods related to tumor activated antibodies targeting PSMA and effector cell antigens

Compositions and methods related to tumor activated antibodies targeting PSMA and effector cell antigens

US Patent 11555078 · Granted Jan 17, 2023

Estimated economic value: $16,485,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods related to tumor activated antibodies targeting EGFR an2025
Compositions and methods related to tumor activated antibodies targeting EGFR an2025
Compositions and methods related to tumor activated antibodies targeting EGFR an2024
Compositions and methods related to tumor activated antibodies targeting EGFR an2024
Transglutaminase 2 (TG2) inhibitors2024
Transglutaminase 2 (TG2) inhibitors2023
Cleavable linker compositions and methods2022
Cleavable linker compositions and methods2022
Broad spectrum antibiotics2019
Modulation of tissue transglutaminase activation in disease2018
Point of care assays to detect the status of tuberculosis infection2017
Linear peptide antibiotics2017